Previous studies reported that pro-inflammatory cytokines, such as IL-1β, IL-6, IL-17, and IL-22, in the blood reduced significantly and were observed in a CRC patient trial with consumption of 6-month probiotics (IL-1 is required for tumor invasiveness and angiogenesis) (Samara et al., 2022). This evidence concerns the gene IL6 and neoplasm.